Mon - Fri: 9:00 - 18:00
Sat-Sun Closed
+38 (057) 750-89-90
+38 (099) 714-27-95
sr7508990@gmail.com

Plagiarism is unacknowledged copying or an attempt to misattribute original authorship, whether of ideas, text or results.

 Plagiarism can be said to have clearly occurred when large chunks of text have been cut-and-pasted without appropriate and unambiguous attribution. Such manuscripts would not be considered for publication in journal «ScienceRise: Pharmaceutical Science». "Text recycling" or reuse of parts of text from an author's previous research publication is a form of self-plagiarism.

 Duplicate publication occurs when an author reuses substantial parts of his or her own published work without providing the appropriate references. This can range from publishing an identical paper in multiple journals, to only adding a small amount of new data to a previously published paper.

 Journal «ScienceRise: Pharmaceutical Science» editors assess all such cases on their individual merits. When plagiarism becomes evident post-publication, we may correct or retract the original publication depending on the degree of plagiarism, context within the published article and its impact on the overall integrity of the published study.
In case of detection of copyright infringement (plagiarism) after publication, the article is not deleted from the journal’s archive (on the website) and is marked as “PLAGIARISM” in accordance with international protocols of anti-plagiarism policy. This article marked as "PLAGIARISM" appears in all resources in which the journal is indexed. The editorial office may impose penalties within the framework of the material and moral damage caused to the Licensee in accordance with clause 6.4 of License agreement.

 Material submitted to a «ScienceRise: Pharmaceutical Science» journal must be original and not published or submitted for publication elsewhere. This rule applies to material submitted elsewhere while the «ScienceRise: Pharmaceutical Science» journal contribution is under consideration.

 All manuscripts submitted for consideration to the journal “ScienceRise: Pharmaceutical Science” are checked for uniqueness by specialized service StrikePlagiarism.com. A manuscript can be accepted for consideration only if it is unique at least 80%.

 Also, in addition, the uniqueness of the manuscript is evaluated at the stage of double-blind peer review (as one of the criteria that is evaluated by reviewers).

 If the manuscript was also submitted for consideration in another journal, the authors are required to report this when submitting the manuscript to the journal “ScienceRise: Pharmaceutical Science”.

Image

Shatilova dacha str., 4, of. 702,
Kharkiv, Ukraine, 61145

+38 (057) 750-89-90
+38 (099) 714-27-95
+38 (093) 973-05-48
+38 (096) 645-23-68 

sr7508990@gmail.com
© PC Technology Center, 2020